Qing (Becky) Lin, Ph.D.
Becky helps biotechnology and pharmaceutical companies (including U.S., European and Chinese companies) obtain strategic patent protection for their technologies, minimize patent infringement risks, and facilitate their IP-related business transactions. She drafts and prosecutes patent applications related to various technologies, such as immunotherapeutics, proteins, genes, small molecules, pharmaceutical compositions, disease diagnosis and treatment, nucleic acid analysis, medical devices, and transgenic animals and plants. Becky also provides patentability, validity, freedom to operate, and non-infringement analyses and opinions in these areas.
Becky’s technical background includes 15 years of research and study in biological sciences. She earned a B.S. in Cell Biology at Lanzhou University (China), an M.S. in Plant Physiology at the Institute of Botany, Chinese Academy of Sciences, and a Ph.D. in Molecular Biology at the University of Missouri-Columbia where she was awarded a Molecular Biology Fellowship. Becky also worked as a research scientist at the Institute of Oceanology, Chinese Academy of Sciences, and conducted post-doctoral research in plant signal transduction at the University of Missouri-Columbia. She received her J.D. with honors at the University of Washington and was an editor for the University of Washington Law Review.
University of Washington
University of Missouri-Columbia
Institute of Botany, Chinese Academy of Sciences
Lanzhou University (China)
Becky is admitted to the Washington State Bar and is registered to practice before the U.S. Patent and Trademark Office. She is a member of the Washington State Bar Association, the American Bar Association, the Washington State Patent Law Association, and the Washington Biomedical and Biotechnology Association.
Honors & Awards
Listed in The Best Lawyers in America®, 2014-2022
Awarded with Lexology’s Client Choice Award for Intellectual Property – Patents, 2017
Selected to Washington Rising Stars®, 2004, 2006, 2009-2010